Evaluation of phentermine and fenfluramine, alone and in combination, in normal, healthy volunteers

Neuropsychopharmacology

Volumn 14, Issue 4, 1996, Pages 233-241

  Brauer, Lisa H ^a   Johanson, Chris Ellyn ^b   Schuster, Charles R ^b   Rothman, Richard B ^c   De Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMPHETAMINE; FENFLURAMINE; PHENTERMINE; PLACEBO;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABUSE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT; DRUG COMBINATION; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE;

ADULT; DRUG THERAPY, COMBINATION; FEMALE; FENFLURAMINE; HUMANS; MALE; PHENTERMINE; REFERENCE VALUES;

EID: 0029665638     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00113-R     Document Type: Article

References (55)

1. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, rev ed 3. Washington DC, American Psychiatric Association
2. Baselt RC, Cravey RH (1989): Disposition of Toxic Drug and Chemicals in Man. Chicago, Year Book Medical Publishers
3. Brauer LH, de Wit H (1995): Role of dopamine in d-amphetamine-induced euphoria in normal, healthy volunteers. Exp Clin Psychopharmacol 3:371-381
4. Brauer LH, Rukstalis MR, de Wit H (1995): Acute subjective responses to paroxetine in normal volunteers. Drug Alcohol Dep 39:223-230
5. Carroll ME, Lac ST, Asencio M, Kragh R (1990a): Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 35:237-244
6. Carroll ME, Lac ST, Asencio M, Kragh R (1990b): Intravenous cocaine self-administration in rats is reduced by dietary L-tryptophan. Psychopharmacology 100:293-300
7. Chait LD, Uhlenhuth EH, and Johanson CE (1985): The discriminative stimulus and subjective effects of d-amphetamine in humans. Psychopharmacology 86:307-312
8. Chait LD, Uhlenhuth EH, Johanson CE (1986): The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans. Psychopharmacology 89:301-306
9. Chait LD, Uhlenhuth EH, Johanson CE (1987): The reinforcing and subjective effects of several anorectics in normal human volunteers. J Pharmacol Exp Ther 242:777-783
10. Corwin RL, Woolverton WL, Schuster CR, Johanson CE (1987): Anorectics: Effects on food intake and self-administration in rhesus monkeys. Alcohol Drug Res 7:351-361
11. Dackis CA, Gold MS (1985): New concepts in cocaine addiction: The dopamine depletion hypothesis. Neurosci Biobehav Rev 9:469-477
12. Di Chiara G, Imperato A (1988): Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci 85(14):5274-5278
13. Evans SM, Zacny JP, Johanson CE (1990): Three-choice discrimination between d-amphetamine, fenfluramine and saline in pigeons. Pharmacol Biochem Behav 35:971-980
14. Fischman MW, Foltin RW (1991): Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addiction 86:1563-1570
15. Folstein MF, Luria R (1973): Reliability, validity, and clinical applications of the visual analogue mood scale. Psychol Med 3:479-486
16. Foltin RW, Fischman MW (1991): Assessment of abuse liability of stimulant drugs in humans: A methodological survey. Drug Alcohol Dep 28:3-48
17. Griffith JD, Nutt JG, Jasinski DR (1975): A comparison of fenfluramine and amphetamine in man. Clin Pharmacol Therap 18:563-570
18. Griffith JD, Jasinski DR, Pevnick JS (1976): Chlorphentermine: Absence of amphetamine-like profile in man. Clin Pharmacol Therap 19:107
19. Griffiths RR, Winger G, Brady JV, Snell JD (1976): Comparison of behavior maintained by infusions of eight phenylethylamines in baboons. Psychopharmacology 50: 251-258
20. Griffiths RR, Brady JV, Snell JD (1978): Progressive-ratio performance maintained by drug infusions: Comparison of cocaine, diethylpropion, chlorphentermine, and fenfluramine. Psychopharmacology 56:5-13
21. Haertzen CA, Hill HE, Belleville RE (1963): Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs. Psychopharmacology 4:155-166
22. Hindmarch I, Kerr JS, Sherwood N (1991): The effects of alcohol and other drugs on psychomotor performance and cognitive function. Alcohol Alcoholism 26:71-79
23. Hitzig P (1993): Combined dopamine and serotonin agonists: A synergistic approach to alcoholism and other behaviors. Maryland Med J 42(2):153-156
24. Hitzig P (1994): Combined serotonin and dopamine indirect agonists correct alcohol-associated neuroses. J Substance Abuse Treat 11(5):489-490
25. Johanson CE, Uhlenhuth EH (1980): Drug preference and mood in humans: d-amphetamine. Psychopharmacology 71:275-279
26. Johanson CE, Uhlenhuth EH (1981): Drug preference and mood in humans: Repeated assessment of d-amphetamine. Pharmacol Biochem Behavior 14:159-163
27. Koob GF, Bloom FE (1988): Cellular and molecular mecha-nism of drug dependence. Sci 242:715-723
28. Leonard BE (1992): Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance. Drugs 43 (Suppl 2):3-10
29. Lyness WH (1983): Effect of L-tryptophan pretreatment on d-amphetamine self-administration. Substance Alcohol Actions/Misuse 4:305-312
30. Lyness WH, Friedle NM, Moore KE (1980): Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic neurons. Pharmacol Biochem Behav 12:937-941
31. Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971): Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245-258
32. McNair DM, Lorr M, Droppleman LF (1971): Profile of Mood States (Manual). San Francisco, Educational and Industrial Testing Service
33. Nuotto EJ, Kortilla KT (1991): Evaluation of a new psychomotor test battery: Effects of alcohol. Pharmacol Toxicol 68:360-365
34. Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS (1975): Fenfluramine: A review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 10(4):241-323
35. Porrino LJ, Ritz MC, Goodman NL, Sharpe LG, Kuhar MJ, Goldberg SR (1989): Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. Life Sci 45:1529-1535
36. Ritz MC, Kuhar MJ (1989): Relationship between self-administration of amphetamine and monoamine receptors in brain: Comparison with cocaine. J Pharmacol Exp Ther 248:1010-1018
37. Roberts DCS (1992): Self-administration of stimulants and serotonergic systems. In Harris L (ed), Problems of Drug Dependence, 1991. National Institute on Drug Abuse Research Monograph Number 119. Washington, DC, U.S. Government Printing Office, pp 136-140
38. Rose JE, Levin ED (1991): Concurrent agonist-antagonist administration for the analysis and treatment of drug dependence. Pharmacol Biochem Behav 41:219-226
39. Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Lane JD, Ripka GV (1994a): Combined effects of nicotine and mecamylamine in attenuating smoking satisfaction. Exp Clin Psychopharmacol 2(4):328-344
40. Rose JE, Behm FM, Westman EC, Levin ED, Stein RM, Lane JD, Ripka GV (1994b): Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmacol Ther 56(1):86-99
41. Rothman RB, Gendron T, Hitzig P (1994): Letter to the editor. J Substance Abuse Treat 11(3):273-275
42. Schuster CR, and Johanson CE (1988): Relationship between the discriminative stimulus properties and subjective effects of drugs. In Colpaert FC, Balster RL (eds), Transduction Mechanisms of Drug Stimuli, Berlin, Springer-Verlag, pp 161-175
43. Smith FL, Yu DSL, Smith DG, Leccese AP, Lyness WH (1986): Dietary tryptophan supplements attenuate amphetamine self-administration in the rat. Pharmacol Biochem Behav 25:849-855
44. Stone BM (1984): Paper and pencil tests - sensitivity to psychotropic drugs. Br J Clin Pharmacol 18:15S-20S
45. U.S. Department of Health and Human Services (1991a): Annual Emergency Room Data 1990. Data from the Drug Abuse Warning Network (DAWN). Washington DC, U.S. Government Printing Office
46. U.S. Department of Health and Human Services (1991b). Annual Medical Examiner Data 1990. Data from the Drug Abuse Warning Network (DAWN). Washington, DC, U.S. Government Printing Office
47. Wechsler D (1958): The Measure and Appraisal of Adult Intelligence, ed. 4. Baltimore, Williams & Wilkins
48. Weintraub M (1992a): Long-term weight control study: Conclusions. Clin Pharmacol Ther 51:642-646
49. Weintraub M (1992b): Long-term weight control study: The National Heart, Lung, and Blood Institute funded multimodal intervention study. Clin Pharmacol Ther 51:581-585
50. Weintraub M, Hasday JD, Mushlin AI, Lockwood DH (1984): A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. Arch Int Med 144:1143-1148
51. Weintraub M, Rubio A, Golik A, Byrne L, Scheinbaum ML (1991): Sibutramine in weight control: A dose-ranging, efficacy study. Clin Pharmacol Ther 50:330-337
52. Weintraub M, Sundaresan PR, Cox C (1992a): Long-term weight control study. IV. Individual participant response patterns. Clin Pharmacol Ther 51:619-633
53. Weintraub M, Sundaresan PR, Madan M, Schuster B, Balder A, Lasagna L, Cox C (1992b): Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo. Clin Pharmacol Ther 51:586-594
54. Wise RA (1984): Neural mechanisms of the reinforcing action of cocaine. In Grabowski J (ed), Cocaine: Pharmacology, Effects, and Treatment of Abuse, NIDA Research Monograph No. 50. Washington, DC, U.S. Government Printing Office, pp 15-33
55. Yu DSL, Smith FL, Smith DG, Lyness WH (1986): Fluoxetine-induced attenuation of amphetamine self-administration in rats. Life Sci 39:1383-1388